BioVersys AG | WebDisclosure

Basculer en Français

10914	Companies
238063	Keywords
166928	Articles
127889	Press releases

Home
Companies
BioVersys AG

PRESS RELEASE

published on 04/15/2026 at 07:00, 4 months 17 days ago

BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026
BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026. CEO Marc Gitzinger to discuss funding and policy priorities in infectious disease research at the congress

Clinical Pipeline Antibacterial Products BioVersys ESCMID Global 2026 Preclinical Pipeline
BRIEF

published on 04/13/2026 at 07:05, 4 months 19 days ago

BioVersys fait progresser le traitement de la tuberculose grâce à AlpE

BioVersys Résistance Aux Médicaments Tuberculose Alpibectir Ethionamide
BRIEF

published on 04/13/2026 at 07:05, 4 months 19 days ago

BioVersys Advances Tuberculosis Treatment with AlpE

Drug Resistance BioVersys Tuberculosis Alpibectir Ethionamide
PRESS RELEASE

published on 04/13/2026 at 07:00, 4 months 19 days ago

Data published in Nature Communications highlights unique Mechanism of Action of Alpibectir in combination with Ethionamide (AlpE)
BioVersys AG and partners publish pre-clinical development data of AlpE in Nature Communications, showcasing unique Mechanism of Action targeting drug-resistance in tuberculosis

BioVersys AG Tuberculosis Nature Communications AlpE Drug-resistance
BRIEF

published on 04/07/2026 at 07:05, 4 months 25 days ago

BioVersys annonce la tenue de son assemblée générale annuelle des actionnaires en 2026.

Élections Du Conseil D'administration Innovation Pharmaceutique Inscription Des Actionnaires Assemblée Générale Annuelle De BioVersys 2026 États Financiers 2025
BRIEF

published on 04/07/2026 at 07:05, 4 months 25 days ago

BioVersys Announces 2026 Annual General Meeting of Shareholders

Board Elections Pharmaceutical Innovation Shareholder Registration BioVersys AGM 2026 Financial Statements 2025
PRESS RELEASE

published on 04/07/2026 at 07:00, 4 months 25 days ago

BioVersys Issues Invitation to its 2026 Annual General Meeting of Shareholders
BioVersys issues invitation to its 2026 AGM, including key agenda items and election updates. Shareholders' participation details provided

Shareholders AGM Meeting 2026 BioVersys
BRIEF

published on 04/02/2026 at 07:05, 5 months ago

BioVersys nomme Anca Cighi à la tête des relations avec les investisseurs

Biopharmaceutique Relations Avec Les Investisseurs BioVersys Anca Cighi Résistant Aux Médicaments
BRIEF

published on 04/02/2026 at 07:05, 5 months ago

BioVersys Names Anca Cighi as Head of Investor Relations

Investor Relations Biopharmaceutical BioVersys Anca Cighi Drug-resistant
PRESS RELEASE

published on 04/02/2026 at 07:00, 5 months ago

BioVersys Appoints Anca Cighi as Head of Investor Relations and Communications
BioVersys AG appoints Anca Cighi as Head of Investor Relations and Communications. Anca brings 15 years of experience to the role

Investor Relations Communications BioVersys AG Antibacterial Products Anca Cighi

Accesswire

Published on 09/01/2026 at 23:05, 12 hours 10 minutes ago

Aton Announces US$30M Credit Facility with OU Moonrider
Published on 09/01/2026 at 22:30, 12 hours 45 minutes ago

Algo Grande Copper Closes Oversubscribed Private Placement for $4.786 Million
Published on 09/01/2026 at 22:15, 13 hours ago

NuRAN Wireless Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
Published on 09/01/2026 at 20:40, 14 hours 35 minutes ago

Tocvan Provides Corporate Update
Published on 09/01/2026 at 16:10, 19 hours 5 minutes ago

Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development

View all ACCESSWIRE

EQS Group

Published on 09/02/2026 at 11:05, 10 minutes ago

Industry Leaders Outline the Future of Energy Independence for European Business in The Economist Panel Ahead of IFA 2026
Published on 09/02/2026 at 10:54, 21 minutes ago

Rixos Hotels Egypt Celebrates Seven Prestigious Wins at the World Travel Awards Africa 2026
Published on 09/02/2026 at 10:15, 1 hour ago

Skyven Arcturus Heat Pump Achieves COP of 8.0, Marking A New Level of Industrial Steam Efficiency
Published on 09/02/2026 at 10:10, 1 hour 5 minutes ago

BOC Group Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Digital Twin of an Organization Platforms
Published on 09/02/2026 at 10:05, 1 hour 10 minutes ago

Thunes Champions Ethical Global Payments with its 2026 United Nations Global Compact Commitment

Les Echos

Published on 09/02/2026 at 11:09, 6 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 09/02/2026 at 07:43, 3 hours 31 minutes ago

Accor launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2032 for a nominal amount of €380 million and a concurrent partial repurchase offer with respect to its outstanding OCEANEs due 2027 by
Published on 09/02/2026 at 07:43, 3 hours 31 minutes ago

Accor lance une émission d’obligations à option de conversion en actions nouvelles et/ou d’échange en actions existantes (OCEANEs) à échéance 2032 pour un montant nominal de 380 millions d’euros et une offre concomitante de rachat partiel de s
Published on 09/01/2026 at 19:00, 16 hours 15 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 19:00, 16 hours 15 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE